Effect of Hypertonic Solutions on Allergic Rhinitis Patients
NCT ID: NCT02233426
Last Updated: 2014-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2014-09-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
NCT03644680
Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact
NCT05042830
The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study
NCT06806826
Effect of Home Environment Regulation on Symptom Control and Quality of Life in Children With Allergic Rhinitis
NCT04479085
Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients
NCT04729517
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who used hypertonic nasal solution alone for at least one month were included as sthe study group
* Patients who used nasal steroid spray alone or at least one month were included as sthe study group
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Namik Kemal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zafer Ciftci
Assist. Prof., M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zafer Ciftci, Assist. Prof
Role: PRINCIPAL_INVESTIGATOR
Namik Kemal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Namik Kemal University, Department of Otorhinolaryngology
Tekirdağ, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zafer Ciftci, Assist. Prof
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NKU-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.